Agomelatine Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

Agomelatine Market

Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model
of depression.

The global Agomelatine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-38A7702/Global_Agomelatine_Market_Insights_and_Forecast_to_2028

North American market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Agomelatine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Purchase Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-38A7702/Global_Agomelatine_Market_Insights_and_Forecast_to_2028

The key global manufacturers of Agomelatine include Servier, Rovi Pharma, Novartis, Nectid Inc and Jiangsu Haosen Pharmaceutical Group, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Agomelatine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agomelatine.

The Agomelatine market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Agomelatine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Agomelatine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Type
• Serotonin 2C Agonist
• Melatonin Receptor 2 Agonist
• Melatonin Receptor 1 Agonist
• Serotonin Receptor Agonist
• Serotonin 2C Receptor Antagonist

By Application
• Depression
• Obsessive Compulsive Disorder
• Sleep Disorders
• Generalized Anxiety Disorder
• Multiple Sclerosis
• Systemic Traumatic Pain
• Autism

Key Players
Servier, Rovi Pharma, Novartis, Nectid Inc, Jiangsu Haosen Pharmaceutical Group

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-38A7702/global-agomelatine

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.